EXTH-31. INCREASING TUMOR TREATING FIELDS (TTFIELDS) EFFICACY BY TARGETING THE G2 CELL CYCLE CHECKPOINT WITH WEE1 OR CHK1 INHIBITORS IN GLIOBLASTOMA CELL LINES
Paul L.G. Slangen(The Netherlands Cancer Institute), Gerben R. Borst(Manchester Academic Health Science Centre), Mariska van Geldorp(Dutch Cancer Society), Olaf van Tellingen(The Netherlands Cancer Institute), Mark C. de Gooijer(Manchester Academic Health Science Centre)
Cited by 0
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy
|Clinical Cancer Research|2014|147
Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2
|Neoplasia|2018|137
An Experimenter’s Guide to Glioblastoma Invasion Pathways
|Trends in Molecular Medicine|2018|125